ArticleThe Journal of adolescent health : official publication of the Society for Adolescent Medicine2019
Availability of Naloxone in Pharmacies and Knowledge of Pharmacy Staff Regarding Dispensing Naloxone to Younger Adolescents.
Article in The Journal of adolescent health : official publication of the Society for Adolescent Medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Naloxone Disparities in Adolescents: Access Laws Are Not Enough.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2025Article
- The Call for a School-Based Approach to Opioid Overdose Prevention.American journal of public health · 2024Article
- Naloxone Dispensing to Youth Ages 10-19: 2017-2022.Pediatrics · 2024Article
- Emergency department management of opioid use disorder in pediatric patients.Journal of the American College of Emergency Physicians open · 2024Article
- Acute opioid overdose in pediatric patients.Journal of the American College of Emergency Physicians open · 2024Article
- Naloxone expansion is not associated with increases in adolescent heroin use and injection drug use: Evidence from 44 US states.The International journal on drug policy · 2023Article
- The policy landscape for naloxone distribution in four states highly impacted by fatal opioid overdoses.Drug and alcohol dependence reports · 2023Article
- Policy Makers' Priorities for Addressing Youth Substance Use and Factors That Influence Priorities.Psychiatric services (Washington, D.C.) · 2022Article
- Protocol for the Optimizing Naloxone Dispensing in Pharmacies (ONDP) Online Continuing Education Program: A Randomized Controlled Trial.Pharmacy (Basel, Switzerland) · 2022Article
- Limited access to pharmacy-based naloxone in West Virginia: Results from a statewide purchase trial.Drug and alcohol dependence · 2022Article
- Naloxone availability in independent community pharmacies in Georgia, 2019.Substance abuse treatment, prevention, and policy · 2021Article
- Expanding Mail-Based Distribution of Drug-Related Harm Reduction Supplies Amid COVID-19 and Beyond.American journal of public health · 2021Article
- Commentary on Hill et al.: Breaking down barriers-increasing access to lifesaving opioid use disorder medications to save lives.Addiction (Abingdon, England) · 2021Article
- What Is Known about Community Pharmacy-Based Take-Home Naloxone Programs and Program Interventions? A Scoping Review.Pharmacy (Basel, Switzerland) · 2021Article
- Considering the Potential Benefits of Over-the-Counter Naloxone.Integrated pharmacy research & practice · 2021Review
- Youth Access to Naloxone: The Next Frontier?The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2019Article
- Barriers and Facilitators to Naloxone Access for Adolescents: A Narrative Review.Substance use : research and treatmentReview
Corrections and comments
- Commented on by
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study assessed the immediate availability of naloxone in pharmacies and the knowledge of pharmacy staff regarding naloxone dispensing protocols, especially as it relates to younger adolescents.
methodsThe primary sample included pharmacies in the 10 states with the highest number of opioid-related overdose deaths in 2016; in addition, pharmacies in the 2 states with the highest prevalence of opioid-related overdose deaths in 2016 were also contacted. Researchers simulated a routine conversation between pharmacy staff and a potential customer about the immediate availability of and requirements to purchase naloxone.
resultsThe primary sample included 120 pharmacies (82.5% chain pharmacies; 50.8% rural). The majority (80.3%) had at least one form of naloxone in stock. Pharmacy staff were knowledgeable about prescription and third-party purchasing requirements. However, almost half incorrectly responded that there was a minimum age requirement to purchase naloxone.
conclusionThis study reveals barriers to obtaining naloxone, including a lack of immediate in-store availability and a common misperception that naloxone cannot be dispensed to minors.
Indexed as
Identifiers
31540779What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.